Bioqube Ventures

About The Fund

Bioqube Ventures is a specialist life sciences investment firm founded in 2016. The firm is composed of a team that includes investment professionals, sector experts, and serial entrepreneurs known for their successful track record in building and leading companies through their growth journeys. In 2020, Bioqube Ventures introduced the Bioqube Factory Fund I, a €110 million fund dedicated to the discovery and development of new therapeutic platforms and assets. Their investment strategy is diversified and includes a venture creation model, which is complemented by strategic industry partnerships to guide progress. With a focus on exclusively investing in Europe's most promising innovative science, Bioqube Ventures positions itself as a core facilitator of growth in the healthcare sector. The firm's specialties lie in Seed and Pre-seed investments, with a minimum investment threshold of €100,000 and a maximum of €5,000,000. The preferred 'sweet spot' for their investments is at €1,500,000. Industries in which Bioqube Ventures actively seeks investment opportunities include BioTech, CleanTech, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, Consumer, and Pharmaceutical and Medicine. Their mission is to support the advancement of healthcare innovation by providing necessary capital and expertise to early-stage ventures in these fields. As managing partner of Bioqube Ventures, Dirk Reyn leverages his extensive experience in pharmaceuticals, biopharmaceuticals, and investment, alongside his educational background as a Pharmacist and MBA graduate, to lead the firm and contribute to the burgeoning biotech landscape. Bioqube Ventures is intent on nurturing breakthrough scientific endeavors and facilitating their translation into viable, impactful therapies and products.